158 related articles for article (PubMed ID: 2517724)
1. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas.
Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY
Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study of radioimmunoimaging by 131I-COC183B2 monoclonal antibody in patients with epithelial ovarian cancer.
Qian HN; Feng J; Cui H; Gao BS; Qin SL; Fu TY; Wei P; Fu ZY; Gao SM; Yang ZY
Chin Med J (Engl); 1991 Feb; 104(2):109-13. PubMed ID: 1874008
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of human monoclonal antibody HMD4 against ovarian carcinoma and the study of radioimmunoimaging in nude mice.
Qian HN; Cui H; Feng J; Fu TY; Wei P; Fu ZY
Hum Antibodies Hybridomas; 1990; 1(2):104-10. PubMed ID: 2103352
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line.
Baumal R; Law J; Buick RN; Kahn H; Yeger H; Sheldon K; Colgan T; Marks A
Cancer Res; 1986 Aug; 46(8):3994-4000. PubMed ID: 3731068
[TBL] [Abstract][Full Text] [Related]
5. Radioimaging of human ovarian carcinoma xenograft in nude mice.
Manetta A; Satyaswaroop PG; Hamilton T; Ozols R; Mortel R
Gynecol Oncol; 1987 Nov; 28(3):292-9. PubMed ID: 3678978
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotypic monoclonal antibodies against anti-ovarian carcinoma monoclonal antibody COC166-9. Generation and application.
Qian HN; Lu WY
Chin Med J (Engl); 1994 Feb; 107(2):99-103. PubMed ID: 8194388
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors].
Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K
Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies.
Epenetos AA; Shepherd J; Britton KE; Hawkins L; Nimmon CC; Taylor-Papadimitriou J; Durbin H; Malpas JS; Mather S; Granowska M
Cancer Detect Prev; 1984; 7(1):45-9. PubMed ID: 6367983
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of monoclonal antibody to a 60-kD glycoprotein in ovarian carcinoma.
Bhattacharya M; Chatterjee SK; Gangopadhyay A; Barlow JJ
Hybridoma; 1985; 4(2):153-62. PubMed ID: 3891588
[TBL] [Abstract][Full Text] [Related]
10. Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas.
Mettler L; Radzun HJ; Salmassi A; Köchling W; Parwaresch MR
Cancer; 1990 Apr; 65(7):1525-32. PubMed ID: 2178766
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P
J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452
[TBL] [Abstract][Full Text] [Related]
12. Identification of a human cancer-associated antigen defined with monoclonal antibody.
Bhattacharya M; Chatterjee SK; Barlow JJ
Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708
[TBL] [Abstract][Full Text] [Related]
13. [Biodistribution, pharmacokinetics and imaging of 131I-labeled HMD4 human McAb in human ovarian carcinoma xenograft in nude mice].
Cui H
Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):80-3, 123. PubMed ID: 2364795
[TBL] [Abstract][Full Text] [Related]
14. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.
Epenetos AA; Britton KE; Mather S; Shepherd J; Granowska M; Taylor-Papadimitriou J; Nimmon CC; Durbin H; Hawkins LR; Malpas JS; Bodmer WF
Lancet; 1982 Nov; 2(8306):999-1005. PubMed ID: 6127540
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study on human epithelial ovarian carcinoma after radioimmunodetection with 131I-labelled polyclonal antibodies].
Yang XY
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):346-9. PubMed ID: 1782846
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.
Chen J; Zhang C; Guo Y; Chang X; Ma R; Ye X; Cheng H; Li Y; Cui H
World J Surg Oncol; 2020 Apr; 18(1):66. PubMed ID: 32252772
[TBL] [Abstract][Full Text] [Related]
17. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
Qian HN; Feng J; Fu TY
Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against human urinary bladder carcinomas: selectivity and utilization for gamma scintigraphy.
Bubeńik J; Kieler J; Perlmann P; Paulie S; Koho H; Christensen B; Dienstbier Z; Koprivová H; Pospísil J; Poucková P
Eur J Cancer Clin Oncol; 1985 Jun; 21(6):701-10. PubMed ID: 3894033
[TBL] [Abstract][Full Text] [Related]
19. Immuno-histological characterization of OVS1 and OVS2 monoclonal antibodies recognizing human ovarian mucinous cystadenocarcinoma.
Neungton N; Moongkarndi P; Laohathai K; Neungton S; Juntrachotiwit P
Asian Pac J Allergy Immunol; 1992 Dec; 10(2):129-34. PubMed ID: 1284830
[TBL] [Abstract][Full Text] [Related]
20. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
